Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II
Abstract Purpose The treatment with anti-VEGF for Retinopathy of prematurity (ROP) has already been widely applied in clinics even though there are still many concerns about this treatment. In this project we investigated the clinical outcomes of intra-vitreous conbercept (IVC) and ranibizumab (IVR)...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-08-01
|
| Col·lecció: | BMC Pediatrics |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12887-024-05017-1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|